Several laboratories have used recombinant DNA technology in plant breeding to improve compositional, processing, and agronomic characteristics of plants. These transformed plants have been extensively tested in eld trials, have gained full regulatory approvals and are currently being marketed in a number of countries around the world. This paper brie y summarizes the approach used to assure the safety of foods and feeds derived from these genetically modi ed crops, as exempli ed by data on Roundup Ready soybeans that has been developed by Monsanto Company using biotechnology in order to confer tolerance to glyphosate, the active ingredient in Roundup herbicide, by the production of the CP4 enolpyruvylshikimate-3-phosphat e synthase protein. The results of the studies demonstrat e that Roundup Ready soybeans are as safe as traditional soybeans with respect to food and feed safety.
INTRODUCTION
Several laboratories have used recombinant DNA technology in plant breeding to improve compositional, processing, and agronomic characteristics of plants. These transformed plants have been extensively tested in eld trials, have gained full regulatory approvals and are currently being marketed in a number of countries around the world. This presentation will brie y summarize the approach used to assure the safety of foods and feeds derived from these genetically modi ed crops. This approach is based on the guidance provided by international organizations such as the World Health Organization (WHO), the United Nations Food and Agricultural Organization (FAO) (12) , and the Organization for Economic Cooperation and Development (OECD). These organizations have accepted the concept of substantial equivalence as a cornerstone of the food safety assessment and depending on the extent of change in terms of composition, a tiered approach to safety assessment is recommended.
Using modern biotechnology, Monsanto Company has developed Roundup Ready soybean varieties that confer tolerance to glyphosate, the active ingredient in Roundup herbicide, by the production of the CP4 enolpyruvylshikimate -3-phosphate synthase (EPSPS) protein. The EPSPS enzyme is present in the shikimic acid pathway for the biosynthesis of aromatic amino acids in plants and microorganisms. Inhibition of this enzyme by glyphosate leads to a de ciency in the production of aromatic amino acids and lack of growth in plants. The aromatic amino acid biosynthetic pathway is not present in mammalian, avian, or aquatic life forms, which explains the selective activity of glyphosate in plants and glyphosate's low mammalian toxicity. Roundup Ready soybean event 40-3-2 was produced by introduction of the naturally glyphosate tolerant cp4 epsps coding sequence into the soybean genome using particle-acceleration transformation. The CP4 EPSPS protein, derived from a common soil bacterium, is a member of the class of EPSPS proteins found ubiquitously in plants and microorganisms.
Key data that are developed for assessing the safety of genetically modi ed crops include: molecular characterization of the insert, an assessment of the gene expression product, agronomic characterization, and a comparative assessment of the chemical composition of the modi ed crop (key nutrients, antinutrients or toxicants). The overall goal of this assessment is to determine whether the genetically modi ed plant is substantially equivalent to the conventional plant, which has a history of safe use. If the transgenic product and counterpart are substantially equivalent in all respects but the introduced traits, then the safety assessment focuses on the introduced trait and the protein expression product of the cloned gene. The biological function/speci city, mode of action of the protein, and the history of known consumption determine the kind and extent of assessment undertaken. A key aspect of the safety testing of the newly introduced protein is the determination of its amino acid sequence and comparison to known sequences to determine if the protein has sequence homology to known toxins or allergens. The inherent digestibility of the protein in simulated gastric and intestinal preparations and stability to heat provide useful information for assessing the potential toxicity and allergenicity of the protein. The lack of toxicity of the protein is con rmed by evaluating the acute toxicity of the protein in mice. The level of protein expressed in the appropriate raw agricultural plant product or a speci c processed food is determined to assess the extent of human exposure and margins of exposure and safety.
Finally, on a case-by-case basis, toxicological and nutritional endpoints are evaluated in comparative rat feeding studies using the genetically modi ed crop and its nontransgenic counterpart. To establish equivalence of feeds from genetically modi ed crops, comparative wholesomeness studies are also conducted in livestock and poultry. Food and feed safety data for Roundup Ready Soybean based on these principles are presented here.
MOLECULAR CHARACTERIZATION OF ROUNDUP READY
SOYBEANS Roundup Ready soybean event 40-3-2 was produced by particle-acceleration transformation (9, 24) of the nontransgenic parental soybean line A5403 utilizing DNA derived from plasmid PV-GMGT04. The primary insertion of DNA derived from the transformation plasmid PV-GMGT04 includes a single cp4 epsps gene cassette: the E35S promoter, the chloroplast transit peptide and cp4 epsps coding sequences, and the nos 3 transcriptional terminator. The cp4 epsps coding sequence, including translation start and stop codons, encodes 456 amino acids, and results in the synthesis of the full length and functional 46-kDa CP4 EPSPS protein in Roundup Ready soybean event 40-3-2 as con rmed by western blotting, enzyme-linked immunosorbent assay (ELISA) and EPSPS enzyme activity assays (18, 30, 31, 33, 40) .
In addition to the primary functional insert, Roundup Ready soybean event 40-3-2 contains two small segments of inserted DNA: a 250-base pair segment of cp4 epsps DNA located adjacent to the nos 3 transcriptional terminal element of the primary, functional insert and a 72-base pair segment of cp4 epsps DNA that cosegregates with the primary functional insert. The lack of functionality of these two small segments was con rmed by the absence of detectable mRNA or protein based on 1) Northern blot and RT PCR analyses, which demonstrated no detectable transcription of either segment, and 2) Western blot analysis, in which only the predicted, full-length protein encoded by the functional cp4 epsps gene insert was detected.
The inserts are inherited in the expected Mendelian pattern and the stability of the inserts has been demonstrated by molecular analysis of the R3 through the R6 generations of event 40-3-2. In addition, Roundup Ready soybean event 40-3-2 has been in commercial production globally since 1996 with consistent product performance.
ASSESSMENT OF AGRONOMIC PERFORMANCE Roundup Ready soybean event 40-3-2 has been tested in eld trials in the United States, Central and South America, Europe, Central Europe and Canada since 1991. Data col-lected from over 150 eld trials conducted in over a 3-year period prior to commercialization in the United States demonstrate that Roundup Ready event 40-3-2 does not differ signi cantly from conventional soybeans in morphology, seed production (yield), agronomic characteristics such as time to owering and pod set, or vigor (germination or persistence) (40) . In addition, Roundup Ready soybean event 40-3-2 was monitored for its susceptibility to diseases and insects, and there were no differences observed in disease severity or insect infestations between Roundup Ready soybeans and the control plants (40, 55) .
Data published more recently includes yield and glyphosate tolerance (10), fungal resistance (43) , and weed control (27) . These studies con rm the conclusion that tolerance to glyphosate is stably inherited and that there are no unexpected plant pest risks or other risks posed to the environment. Furthermore, the Roundup Ready soybean trait has been introgressed into over 1,000 conventional soybean varieties and no unusual plant pest characteristics or unintended environmental effects have been observed that are attributed to the inserted event, as con rmed by the extensive studies developed prior to, and subsequent to, approval and market introduction. Agronomic performance has been as expected and tolerance to glyphosate has been uniform and consistent in these varieties.
COMPOSITIONAL ANALYSIS OF ROUNDUP READY SOYBEANS The rst step in designing an appropriate nutritional and safety assessment for a genetically engineered crop requires a detailed understanding of the uses of the crop and crop products in animal and human nutrition. Soybean, Glycine max, is one of the world's largest sources of plant protein and oil. Typically, a 60-pound bushel of soybeans yields about 48 pounds of protein-rich meal and 11 pounds of oil (1) . The primary use of the defatted toasted soybean meal is in animal feed (97%). The principle fraction used by the food industry is processed soybean oil, which is utilized in margarines, shortenings and cooking and salad oils. Lecithin, a phosphatide removed from crude soybean oil, is used as a natural emulsi er, lubricant, and stabilizing agent. Soybean akes are also used in various food products, including tofu, soya sauce, and simulated milk and meat products. There are few food uses of unprocessed soybeans, because they naturally contain trypsin inhibitors, which may act as antinutrients if the soybeans are not properly heated during preparation. Industrial uses of soybeans range from the production of yeasts and antibodies to the manufacture of soaps and disinfectants.
Compositional analyses are a critical component of the safety assessment process and combined with the evaluation of the protein produced for the desirable trait provide a reasonable assurance of the safety of the transformed plant (4). Each of the parameters measured provide an assessment of the cumulative result of numerous biochemical pathways and hence provides an assessment of a wide range of metabolic pathways within the plant. Comparisons of various nutrients and antinutrients are made to both a closely related traditional counterpart as well as to the established range for the speci c component within that crop to compare the observed levels to the natural variation of that component in current plant varieties.
Extensive compositional analyses of Roundup Ready soybean event 40-3-2 have been conducted and the results of these studies have been published (10, 22, 30, 35, 49) . Over 1,400 individual analyses have been conducted and establish that the composition of Roundup Ready soybeans is substantially equivalent to the nontransgenic parental soybean variety and other commercial soybean varieties. These analyses included:
Proximate analysis, protein, fat, ber, ash, carbohydrates, and moisture; anti-nutrients, trypsin inhibitors, lectins and phytate; other components relevant to human and animal nutrition, phytoestrogens (genistein and daidzein), stacchyose and raf nose; fatty acid pro le, percentage of individual fatty acids; and amino acid composition, levels of individual amino acids.
The results of proximate analyses conducted on seed from Roundup Ready soybean and the nontransgenic parental control are presented in Table 1 . These analyses were conducted on soybeans grown at six locations across the United States in 1992 and four locations in 1993; the Roundup Ready soybean plants were treated with Roundup herbicide. No statistical differences were observed between the proximate values (protein, ash, moisture, oil, ber, and carbohydrates) for Roundup Ready soybeans and the A5403 control at the 5% con dence level, con rming that the levels of these components in Roundup Ready soybeans are comparable to those of conventional soybeans (49) .
Amino acid analysis was performed on Roundup Ready soybean and the A5403 soybean seed from the 1993 US eld trials ( Table 2 ). The levels of amino acids, including those of the aromatic amino acids (phenylalanine, tyrosine, and tryptophan) were comparable between the two lines. There were no signi cant differences observed at the 5% con dence level for any amino acid analyzed (49) . A summary of phytoestrogen levels from soybean seed harvested from the 1993 US eld trials is provided in Table 3 . The range of total genistein and total diadzein was variable across sites and is re ected in the ranges for both Roundup Ready soybean and the A5403 control soybean seed. However, the mean levels of total genistein and total diadzein in the Roundup Ready soybean seed are comparable to those in the A5403 control seed, and are comparable to iso avone levels reported for eld-grown soybeans (58) . There were no signi cant statistical differences observed at the 5% condence level (49) .
Compositional analyses have also been conducted on various processed fractions of soybeans, including toasted meal, defatted nontoasted meal, protein isolate, protein concentrate, and oil (35) . Roundup Ready and A5403 control soybeans from the 1992 US eld trials were processed into the various fractions using procedures that mimic commercial processing procedures as closely as possible, although the scale was much smaller. The results of proximate analyses conducted on defatted nontoasted soybean meal, isolate, and concentrate are presented in Table 4 . The levels of macronutrients (protein, ash, fat, ber, and carbohydrates) in these fractions made from Roundup Ready soybeans were comparable to the levels in the fractions made from the parental soybean control cultivar. The fatty acid composition of the re ned, bleached, deodorized oil (RBDO) processed from Roundup Ready oil was comparable to RBDO made from the control soybean line ( Table 5) .
List et al (22) performed a detailed characterization of the phosopholipi d composition of Roundup Ready soybean seed. Lecithin derived from Roundup Ready soybeans was compared to commercial lecithin samples and the levels of phosphatidylcholine , phosphatidylethanolamine , phosphatidylinositol, and phosphatidic acid were found to be comparable.
In summary, the results of the analyses demonstrate that soybean seed and food components from Roundup Ready soybean event 40-3-2 are substantially equivalent to soybean seed and food components from conventional soybean varieties.
Safety Assessment of the CP4 EPSPS Protein in Roundup Ready Soybeans
The safety assessment of the CP4 EPSPS protein produced in Roundup Ready soybean event 40-3-2 includes protein characterization, functional, and structural comparisons of CP4 EPSPS protein to ubiquitous plant and microbial EPSPS proteins with a history of safe consumption, in vitro digestibility in simulated gastric and intestinal uids, acute oral toxicity in mice, and amino acid comparison to known toxins and allergens. CP4 EPSPS PROTEIN CHARACTERIZATION The CP4 EPSPS protein produced in Roundup Ready soybeans is functionally similar to a diverse family of EPSPS proteins typically present in food and feed derived from plant and microbial sources (18, 21) . The EPSPS proteins are required for the production of aromatic amino acids in plants and microbes. Genes for numerous EPSPS proteins have been cloned (30, 31) , and active site domains are conserved among the known EPSPS proteins (32, 34) . Bacterial EPSPS proteins have been well characterized with respect to the 3-dimensional X-ray crystal structure (48) and the detailed kinetic and chemical reaction mechanisms (2) . The enzymology and known function of EPSPS proteins generally, and CP4 EPSPS protein speci cally, establish that this class of enzymes performs a well-described and understood biochemical role in plants.
From the perspective of safety, this characterization demonstrates that metabolic effect of the expression of the CP4 EPSPS protein is limited to conferring tolerance to Roundup herbicide. Part of this evaluation includes the known structural relationship of CP4 EPSPS protein with other EPSPS proteins found in food, the comparison of the amino acid sequences with conserved identity of the active site residues, the expected conserved 3-dimensional structure based on similarity of the amino acid sequence, and the fact that EPSPS proteins catalyze a nonrate-limiting step in the aromatic amino acid pathway (hence increases in the level of EPSPS proteins would not be expected to affect the ux through the aromatic amino acid pathway). With respect to amino acid sequence, there is considerable divergence among known EPSPS proteins. For instance, the amino acid sequence of CP4 EPSPS protein is 41% identical at the amino acid level to Bacillus subtilis EPSPS protein, whereas the soybean EPSPS protein is 30% identical to Bacillus subtilis EPSPS protein. Thus, the divergence of the CP4 EPSPS protein amino acid sequence from typical food EPSPS protein sequences is on the same order as the divergence among food EPSPS proteins themselves (18) . The detailed enzymology (18) and biochemical composition evaluations (31) con rm that CP4 EPSPS protein, as expressed in Roundup Ready soybeans, has the predicted metabolic effect: the production of aromatic amino acids via the shikimic acid biosynthetic pathway.
IN VITRO DIGESTIBILITY OF THE CP4 EPSPS PROTEIN
Simulated mammalian gastric and intestinal digestive uids were used in in vitro assays to assess the susceptibility of the CP4 EPSPS protein to proteolytic digestion. Rapid degradation of the protein correlates with limited exposure to the gastrointestinal tract and little likelihood that the protein can produce pharmacological, toxic, or allergenic effects. The method of preparation of the simulated digestion solutions used is described in the United States Pharmacopeia (56) .
The CP4 EPSPS protein was rapidly digested in the in vitro digestive system (18) . Enzyme activity and immunoblot analyses were used to monitor the degradation of CP4 EPSPS protein and demonstrated that the half-life of the protein in simulated gastric uid was less than 15 seconds and less than 10 minutes in simulated intestinal uid. To put the rapid degradation of the CP4 EPSPS protein in the simulated gastric system into perspective, solid food has been estimated to empty from the human stomach by about 50% in 2 hours, while 50% of liquid intake has left the stomach within approximately 25 minutes (46) . If the CP4 EPSPS protein were not degraded in the gastric system, it would be rapidly degraded in the intestine. Proteins that are rapidly degraded in the gastrointestinal tract are unlikely to confer toxicity or allergy (4, 5) .
Assessment of Acute Oral Toxicity of the CP4 EPSPS Protein in Mice
Few proteins are toxic when ingested and those that are toxic typically act in an acute manner (45) . To con rm the lack of acute toxicity, an oral toxicity study with CP4 EPSPS protein as the test material was performed on mice to directly assess any potential toxicity associated with the protein (18) . There were no treatment-related adverse effects in mice administered CP4 EPSPS protein by oral gavage at dosages up to 572 mg/kg of body weight. This dose represents a signi cant-greater than 1,000-fold-safety margin relative to the highest potential human consumption of CP4 EPSPS protein and assumes that the protein is expressed in multiple crops (18) . Results from this study demonstrated that the CP4 EPSPS protein is not acutely toxic to mammals. This TABLE 6.-CP4 EPSPS protein levels (l g of protein/mg of fresh weight of tissue) in Roundup Ready soybean (40-3-2) and parental (A5403) soybean seed and leaf tissue. 40 result was expected since the CP4 EPSPS protein is readily digested in gastric and intestinal uids in vitro and the protein is from a ubiquitous family of proteins with a history of safe consumption and no biologically plausible mechanism of toxicity to animals.
Assessment of Structural Homology of the CP4 EPSPS Protein to Known Protein Toxins
Another aspect used for the assessment of potential toxic effects of proteins introduced into plants is to compare the amino acid sequence of the protein to the sequences of known toxic proteins. Homologous proteins derived from a common ancestor have similar amino acid sequences, are structurally similar and often share common function. Therefore, it is undesirable to introduce DNA, which encodes for a protein that is homologous to a protein that is toxic to animals and humans. Homology is determined by comparing the degree of amino acid similarity between proteins using published criteria (11) . The CP4 EPSPS protein does not show meaningful amino acid sequence similarity when compared to known protein toxins.
ASSESSMENT OF ALLERGENIC POTENTIAL OF CP4 EPSPS PROTEIN Although there are no single predictive bioassays available to assess the allergenic potential of proteins in humans (13) , the physicochemical and human exposure pro le of the protein provides a basis for assessing potential allergenicity by comparing it to known protein allergens. Thus, important considerations contributing to the allergenicity of proteins ingested orally includes exposure and an assessment of the factors that contribute to exposure, such as stability to digestion, prevalence in the food, and consumption pattern (amount) of the speci c food (20, 25) .
A key parameter contributing to the systemic allergenicity of certain food proteins appears to be stability to the peptic and acidic conditions of the digestive system (3, 5, 12, 14, 20) . Important protein allergens tend to be stable to peptic digestion and the acidic conditions of the stomach if they are to reach the intestinal mucosa where an adverse immune response can be initiated. As noted above, the in vitro assessment of the CP4 EPSPS protein digestibility indicates that the protein, like other food-derived proteins, is very labile to digestion when compared to many clinically important food allergens.
Another signi cant factor contributing to the allergenicity of certain food proteins is their high concentrations in foods (14, 49, 50) . Most food allergens are present as major protein components in the speci c food, in amounts ranging from 1% up to 80% of total protein (14) . In contrast, the CP4 EPSPS protein is present at low levels, approximately 0.08% of the total protein, in whole Roundup Ready soybean seed ( Table 6 ) (33) . Furthermore, it has been shown that the processing steps used in the production of soybean oil, one of the main sources of soybean in the human diet, reduce the vast majority of protein such that re ned soybean oil did not trigger allergenic reactions in humans who were sensitive to soybean (8) .
It is also important to establish that the protein does not represent a previously described allergen and does not share potentially immunologically relevant amino acid sequence segments or structure with a known allergen. An ef cient way to determine whether the added protein is an allergen, or is likely to contain cross-reactive structures, is to compare the amino acid sequence of the introduced protein with those of all known allergens. A database of protein sequences associated with allergy and coeliac disease has been assembled from publicly available genetic databases (GenBank, EMBL, PIR, and SwissProt). The amino acid sequence of the CP4 EPSPS protein was compared to these sequences and shown to have no meaningful amino acid sequence similarity with any of the known allergens (14) .
Finally, an assessment of the endogenous allergens in conventional and Roundup Ready soybeans has been made using sera from patients con rmed to be sensitive to soybean protein. This study demonstrated that the introduction of the CP4 EPSPS protein did not cause any discernible changes, either qualitatively or quantitatively, in the composition of the allergenic proteins endogenous to soybean (7) .
In summary, the known function and ubiquity of EPSPS proteins and direct studies with CP4 EPSPS protein demonstrate that this protein does not represent a new risk in the food supply. Results showed that there was no indications of toxicity of the CP4 EPSPS protein as measured by treatmentrelated adverse effects in mice administered the CP4 EPSPS protein by oral gavage. This lack of toxicity was expected based on the rapid degradation of the CP4 EPSPS protein and its enzymatic activity in simulated human gastric and intestinal uids. In addition, CP4 EPSPS protein is not homologous to known protein toxins or allergens and is present at very low levels in Roundup Ready soybeans. Furthermore, this protein is from a family of proteins with a long history of safe consumption.
OVERALL NUTRITIONAL AND TOXICOLOGICAL ASSESSMENT A series of animal feeding studies have been completed using diets incorporating raw or processed soybeans from Roundup Ready soybean event 40-3-2. These studies conrm the nutritional equivalence of event 40-3-2 when used as animal feed and address potential pleiotropic effects caused by the insertion process or site of insertion.
The animal feeding studies included 2 separate 4-week studies in rats, a 4-week dairy cow study, a 6-week chicken study, a 10-week cat sh study and a 5-day quail study (16, 42) . Animals were fed either raw cracked soybean, unprocessed soybean meal, or processed soybean meal (dehulled, defatted, toasted). Included in these studies were control groups fed the nonmodi ed parental soybean line (A5403), from which Roundup Ready soybean event 40-3-2 was derived. Results from all groups were compared using conventional statistical methods to detect differences between groups in measured parameters.
Samples of both Roundup Ready soybeans and the conventional counterpart produced similar growth and feed efciency for rats, chickens, cat sh, and quail (16) . Milk production, composition and rumen fermentation parameters for dairy cows were also comparable across all groups (16) . Results for other parameters measured in each feeding study were also similar across all groups. When compared to the US population as a whole, the levels of soybean consumption (in mg/kg of body weight) in these animal feeding studies were 100-fold or more higher than the average human daily consumption of soybean-derived foods in the United States (54) .
A 15-week study in rats and mice compared the feeding value of Roundup Ready soybeans to that of the parental control (52) . No remarkable compositional differences in fatty acids or amino acids were observed between Roundup Ready soybeans and the nontransgenic control. No signi cant differences in growth, feeding value, and the histopathology of immune-related organs were observed between animals fed Roundup Ready soybean meal and meal from the nontransgenic control. The production of soybean speci c IgE was not detected in sera of either group of animals, and the increase in soybean-speci c IgG was comparable in both groups. No immunotoxic activity was observed in the rats or mice fed Roundup Ready soybeans.
These studies all con rm the food and feed safety and nutritional equivalence of diets prepared from Roundup Ready soybean event 40-3-2 compared to diets prepared from the control soybean varieties. The nutritional value or wholesomeness of Roundup Ready soybean event 40-3-2, even when fed to animals at levels much higher than humans would encounter in the diet, was the same as conventional varieties of soybeans.
CP4 EPSPS Protein Levels in Roundup Ready Soybean Plants
An enzyme-linked immunosorbent assay (ELISA) (17) method was developed and optimized to quantitate CP4 EPSPS protein levels in soybean leaf and seed matrices (30, 41) . Protein levels are presented in Table 6 for soybean seed and leaf tissues collected from Roundup Ready soybean plants that were either unsprayed or sprayed with Roundup herbicide in 1992 and 1993 US eld trials (30) .
The mean level of CP4 EPSPS protein in soybean seed from the 1992 trials was 0.301 l g/mg fresh weight for plants treated with Roundup herbicide and 0.288 l g/mg fresh weight for unsprayed plants. The mean protein levels in seed from the 1993 trials were 0.218 l g/mg fresh weight for plants treated with Roundup herbicide and 0.201 l g/mg fresh weight for unsprayed plants. This level of CP4 EPSPS protein in the seed represents approximately 0.08% of the total protein in the seed. Mean CP4 EPSPS protein levels in soybean leaf tissue from the 1993 trials were 0.489 l g/mg fresh weight for plants treated with Roundup herbicide and 0.415 l g/mg fresh weight for unsprayed plants.
As expected, the CP4 EPSPS protein was not detected in soybean leaf or seed tissue from the nontransgenic A5403 parental variety in either year at the limit of detection.
CONCLUSIONS
In conclusion, the food and feed safety of Roundup Ready soybean was established based on: the safety of the genetic elements contained in the transformation vector used to produce Roundup Ready soybean event 40-3-2; the evaluation of the functional and structural similarity of the CP4 EPSPS protein to a diverse family of EPSPS proteins typically present in food and feed derived from traditional plant and microbial sources; the low dietary exposure to the CP4 EPSPS protein; the lack of toxicity or allergenicity of EPSPS proteins in general; and by direct studies of the CP4 EPSPS protein. Furthermore, the nutritional equivalence and wholesomeness of Roundup Ready soybeans compared to conventional soybeans was demonstrated by the analysis of key nutrients, including proximates, amino acid and fatty acid composition, as well as antinutrients. The equivalence of Roundup Ready soybeans to conventional soybeans was con rmed in numerous feeding studies with rats, cows, broiler chickens, sh, and quail. The results of these studies demonstrate that Roundup Ready soybeans are as safe as traditional soybeans with respect to food and feed safety.
